Want to see IBRX full AI Analyst Report?

ImmunityBio (IBRX) Revenue

2,541 Followers

ImmunityBio Revenue

ImmunityBio had a revenue of 51.24M in the quarter ending Jun 30, 2026, with 15.91%. This bring the company's revenue in the last twelve months to 165.79M, Decreased 17.60%. In the fiscal year ending Dec 31, 2025, ImmunityBio had annual revenue of 113.29M with 668.31% growth.

Revenue (ttm)

165.79M

Revenue Growth

192.92%

P/S Ratio

74.09

Revenue/Employee

$164,663

Employees

688

Market Cap

$8.39B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	113.29M	98.54M	+668.31%
Dec 31, 2024	14.74M	14.12M	+2,270.58%
Dec 31, 2023	622.00K	382.00K	+159.17%
Dec 31, 2022	240.00K	-694.00K	-74.30%
Dec 31, 2021	934.00K	329.00K	+54.38%
Dec 31, 2020	605.00K	562.00K	+1,306.98%
Dec 31, 2019	43.00K	-4.00K	-8.51%
Dec 31, 2018	47.00K	2.00K	+4.44%
Dec 31, 2017	45.00K	―	―